CISR chief visits AMTZ, reviews MedTech ecosystem

Account subscription benefits alongside Premium Stories, Editorials, Opinions and more. Unlock these with Subscription

Dr. N. Kalaiselvi, Director General, Council of Scientific and Industrial Research (CSIR), and Secretary, Department of Scientific and Industrial Research (DSIR), on Tuesday visited AMTZ to witness the key developments shaping the next phase of India’s MedTech ecosystem. Dr. Kalaiselvi interacted with Dr. Jitendra Sharma, MD & Founder CEO, AMTZ, and senior officials, and visited MedTech enterprises including Pyramed, Molbio Diagnostics, Transasia Bio-Medicals and Electra. She participated in the foundation stone ceremony of SS Medical Systems (I) Pvt. Ltd. marking its expansion into indigenous MedTech manufacturing with its OptiMaser technology deployed across 55,000 installations in India. A major highlight was the inauguration of the expanded Medi Valley, AMTZ’s MedTech incubation platform, supported by NITI Aayog, which has grown to a new tower of 1-lakh Sqft. The facility enables startups to transform idea to prototypes in six months and pursue regulatory clearances within 12 months, with access to specialised labs and facilities. Dr. Jitendra Sharma said: “Dr. Kalaiselvi’s visit is a moment of pride and inspiration as we enter our next decade focused on accelerating indigenous innovation, strengthening the MedTech value chain and building an Aatmanirbhar, globally competitive MedTech ecosystem for India.” Dr. Kalaiselvi said, “What Dr. Jitendra Sharma has built at AMTZ is truly remarkable—a complete ecosystem where innovation, research, manufacturing and entrepreneurship converge. AMTZ is a model that deserves to be replicated across India.” She said ecosystems like AMTZ demonstrate the potential of indigenous innovation and strengthen confidence in achieving Viksit Bharat 2047. To strengthen startup research linkages, she said all 37 CSIR laboratories are open to AMTZ startups for research, technology and innovation support.

Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.

We have migrated to a new commenting platform. If you are already a registered user of The Hindu and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.